Replacement of polyps with type 1 macular neovascularization in polypoidal choroidal vasculopathy imaged with swept source OCT angiography

Replacement of polyps with type 1 macular neovascularization in polypoidal choroidal vasculopathy imaged with swept source OCT angiography

Purpose: To investigate the morphological changes of polyps in eyes with polypoidal choroidal vasculopathy (PCV) after treatment with vascular endothelial growth factor (VEGF) inhibitors using swept source optical coherence tomography angiography (SS-OCTA). Observations: Following anti-VEGF therapy,...

Full description

Bibliographic Details
Main Authors:	Mengxi Shen, Qiyu Bo, Minlu Song, Xiaoshuang Jiang, Zohar Yehoshua, Giovanni Gregori, Xiaodong Sun, Fenghua Wang, Philip J. Rosenfeld
Format:	Article
Language:	English
Published:	Elsevier 2021-06-01
Series:	American Journal of Ophthalmology Case Reports
Subjects:	Anti-vascular endothelial growth factor treatment Polypoidal choroidal vasculopathy Polyp Swept source OCT angiography Type 1 macular neovascularization
Online Access:	http://www.sciencedirect.com/science/article/pii/S2451993621000487

Similar Items

Recent Advances in Imaging Polypoidal Choroidal Vasculopathy with Swept-Source Optical Coherence Tomography Angiography
by: Xingwang Gu, et al.
Published: (2023-07-01)

Different Morphology of Branching Neovascular Network in Polypoidal Choroidal Vasculopathy: A Swept-Source Optical Coherence Tomography Angiography Study
by: Lulu Chen, et al.
Published: (2023-01-01)

Choriocapillaris flow deficits in polypoidal choroidal vasculopathy using swept source optical coherence tomography angiography
by: Maanasi Mahalingam, et al.
Published: (2022-01-01)

Eplerenone in the Treatment of Polypoidal Choroidal Vasculopathy
by: Kapil G. Kapoor, et al.
Published: (2015-12-01)

Joint Multimodal Deep Learning-based Automatic Segmentation of Indocyanine Green Angiography and OCT Images for Assessment of Polypoidal Choroidal Vasculopathy Biomarkers
by: Jessica Loo, PhD, et al.
Published: (2023-09-01)

Characteristics of Fundus Autofluorescence in Active Polypoidal Choroidal Vasculopathy
by: Zafer Öztaş, et al.
Published: (2016-08-01)

Treatment Outcomes in Patients with Polypoidal Choroidal Vasculopathy
by: Mümin Hocaoğlu, et al.
Published: (2016-01-01)

Progress in treatment of submacular hemorrhage due to polypoid choroidal vasculopathy
by: Shuang Zhang, et al.
Published: (2019-06-01)

Therapeutic effects of ranibizumab in patients with polypoidal choroidal vasculopathy
by: Xiaoya Gu, et al.
Published: (2019-07-01)

Polypoidal Choroidal Vasculopathy Associated with Optic Disc Coloboma
by: Yumiko Nakano, et al.
Published: (2018-01-01)

Characterization of Choroidal Morphology and Vasculature in the Phenotype of Pachychoroid Diseases by Swept-Source OCT and OCTA
by: Bingjie Qiu, et al.
Published: (2022-06-01)

Comparison of Outcomes between 3 Monthly Brolucizumab and Aflibercept Injections for Polypoidal Choroidal Vasculopathy
by: Yoshiko Fukuda, et al.
Published: (2021-09-01)

Photodynamic Therapy and Bevacizumab Combination for Polypoidal Choroidal Vasculopathy Refractory to Intravitreal Ranibizumab
by: Zeynep Alkin, et al.
Published: (2016-12-01)

Aflibercept for recurrent or recalcitrant polypoidal choroidal vasculopathy in Indian eyes: Early experience
by: Aditya Bansal, et al.
Published: (2017-01-01)

Prevalence of Polypoidal Choroidal Vasculopathy in Eyes with Neovascular Age-Related Macular Degeneration Resistant to Intravitreal Anti-VEGF Treatment
by: Jale Menteş, et al.
Published: (2022-10-01)

Initial experience in treating polypoidal choroidal vasculopathy with brolucizumab in Indian eyes – A multicenter retrospective study
by: DebdulalChakraborty, et al.
Published: (2022-01-01)

Observation of a pulsatile choroidal vascular lesion in a patient with polypoidal choroid vasculopathy during vitrectomy
by: Ting Zhang, et al.
Published: (2022-06-01)

Evolution of Polypoidal Lesions after Treatment of Polypoidal Choroidal Vasculopathy
by: Colin S. Tan, MMed (Ophth), FRCOphth, et al.
Published: (2022-03-01)

Noninvasive multimodal imaging in diagnosing polypoidal choroidal vasculopathy
by: Jingyuan Yang, et al.
Published: (2019-11-01)

Comparison of cytokine levels in the aqueous humor of polypoidal choroidal vasculopathy and neovascular age-related macular degeneration patients
by: Huiying Zhou, et al.
Published: (2020-01-01)

Effect of Epiretinal Membrane Peeling on Intravitreal Aflibercept Therapy Response for Polypoidal Choroidal Vasculopathy: A Case Report
by: Aslı Kırmacı, et al.
Published: (2018-04-01)

Systemic Risk Factors for Vitreous Hemorrhage Secondary to Polypoidal Choroidal Vasculopathy
by: Baoyi Liu, et al.
Published: (2023-08-01)

AFLIBERCEPT IN TREATMENT OF RESISTANT POLYPOID CHOROIDAL VASCULOPATHY: SHORT-TERM RESULTS
by: E. K. Pedanova, et al.
Published: (2017-12-01)

Pachydrusen in polypoidal choroidal vasculopathy in an Indian cohort
by: Sumit Randhir Singh, et al.
Published: (2019-01-01)

Polypoidal choroidal vasculopathy: An update on current management and review of literature
by: Amit Harishchandra Palkar, et al.
Published: (2019-01-01)

One-Year Outcome of Aflibercept and Photodynamic Therapy in a Caucasian Patient with Polypoidal Choroidal Vasculopathy Refractory to Ranibizumab and Photodynamic Therapy
by: Marta Medina-Baena, et al.
Published: (2018-03-01)

Characteristics and racial variations of polypoidal choroidal vasculopathy in tertiary centers in the United States and United Kingdom
by: Tarek Alasil, et al.
Published: (2017-04-01)

Polypoidal Choroidal Vasculopathy after Stereotactic Radiotherapy for Neovascular Age-Related Macular Degeneration: A Case Report with Long-Term Follow-Up
by: Alexandra Steinemann, et al.
Published: (2021-04-01)

Polypoidal Choroidal Vasculopathy: An Update on Therapeutic Approaches
by: Raymond L.M. Wong, et al.
Published: (2013-01-01)

Choroidal nevus and polypoidal vasculopathy: case series
by: Karlos Ítalo S. Viana, et al.
Published: (2020-06-01)

A case of polypoidal choroidal vasculopathy. Periphery is equally important for such patients
by: Dimitrios A Karagiannis, et al.
Published: (2009-06-01)

Short-Term Outcomes of Switching to Ranibizumab in Polypoidal Choroidal Vasculopathy Resistant to Aflibercept Therapy
by: Young-Joon Jeon, et al.
Published: (2021-12-01)

Comparison of intravitreal ziv-aflibercept and bevacizumab monotherapy in treatment-naive polypoidal choroidal vasculopathy
by: Sumit Randhir Singh, et al.
Published: (2019-01-01)

Effect of vitrectomy with intravitreal Conbercept injection for polypoidal choroidal vasculopathy associated with vitreous hemorrhage
by: Jian Shen, et al.
Published: (2018-09-01)

Effect of intravitreal Conbercept on wet age-related macular degeneration and polypoidal choroidal vasculopathy
by: Ying-Chun Li, et al.
Published: (2015-11-01)

Clinical features and progress of surgical therapy for polypoidal choroidal vasculopathy
by: Qing Ren, et al.
Published: (2018-10-01)

One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy
by: Hsin-Yu Weng, et al.
Published: (2019-05-01)

Sub-internal limiting membrane hemorrhage as an unusual presentation of polypoidal choroidal vasculopathy
by: George Joseph Manayath, et al.
Published: (2021-01-01)

Long-term outcomes of focal laser photocoagulation for the treatment of polypoidal choroidal vasculopathy
by: Sooyeon Choe, et al.
Published: (2021-09-01)

Plasma Levels of Matrix Metalloprotease MMP-9 and Tissue Inhibitor TIMP-1 in Caucasian Patients with Polypoidal Choroidal Vasculopathy
by: Jakob Ø. Sørensen, et al.
Published: (2020-05-01)